콘텐츠로 건너뛰기
Merck
  • Fibrinopeptides A and B release in the process of surface fibrin formation.

Fibrinopeptides A and B release in the process of surface fibrin formation.

Blood (2010-11-26)
Tomas Riedel, Jiri Suttnar, Eduard Brynda, Milan Houska, Leonid Medved, Jan E Dyr
초록

Fibrinogen adsorption on a surface results in the modification of its functional characteristics. Our previous studies revealed that fibrinogen adsorbs onto surfaces essentially in 2 different orientations depending on its concentration in the solution: "side-on" at low concentrations and "end-on" at high concentrations. In the present study, we analyzed the thrombin-mediated release of fibrinopeptides A and B (FpA and FpB) from fibrinogen adsorbed in these orientations, as well as from surface-bound fibrinogen-fibrin complexes prepared by converting fibrinogen adsorbed in either orientation into fibrin and subsequently adding fibrinogen. The release of fibrinopeptides from surface-adsorbed fibrinogen and from surface-bound fibrinogen-fibrin complexes differed significantly compared with that from fibrinogen in solution. The release of FpB occurred without the delay (lag phase) characteristic of its release from fibrinogen in solution. The amount of FpB released from end-on adsorbed fibrinogen and from adsorbed fibrinogen-fibrin complexes was much higher than that of FpA. FpB is known as a potent chemoattractant, so its preferential release suggests a physiological purpose in the attraction of cells to the site of injury. The N-terminal portions of fibrin β chains including residues Bβ15-42, which are exposed after cleavage of FpB, have been implicated in many processes, including angiogenesis and inflammation.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Fibrinopeptide A human, ≥96% (HPLC)
Sigma-Aldrich
Fibrinopeptide B human